Jonathan D. Root - 05 Jun 2025 Form 3 Insider Report for Omada Health, Inc. (OMDA)

Role
Director
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root
Issuer symbol
OMDA
Transactions as of
05 Jun 2025
Transactions value $
$0
Form type
3
Date filed
05 Jun 2025, 16:44
Previous filing
19 Feb 2025
Next filing
18 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROOT JONATHAN D Director C/O OMADA HEALTH, INC., 500 SANSOME STREET, SUITE 200, SAN FRANCISCO /s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root 2025-06-05 0001225480

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OMDA Common Stock 32.3K 05 Jun 2025 See footnotes F1, F2, F4
holding OMDA Common Stock 1.03K 05 Jun 2025 See footnotes F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMDA Series A Preferred Stock 05 Jun 2025 Common Stock 1.81M See footnotes F2, F4, F5
holding OMDA Series B Preferred Stock 05 Jun 2025 Common Stock 1.78M See footnotes F2, F4, F5
holding OMDA Series C Preferred Stock 05 Jun 2025 Common Stock 357K See footnotes F2, F4, F5
holding OMDA Series C-1 Preferred Stock 05 Jun 2025 Common Stock 259K See footnotes F2, F4, F5
holding OMDA Series D Preferred Stock 05 Jun 2025 Common Stock 334K See footnotes F2, F4, F5
holding OMDA Series A Preferred Stock 05 Jun 2025 Common Stock 58K See footnotes F3, F4, F5
holding OMDA Series B Preferred Stock 05 Jun 2025 Common Stock 56.8K See footnotes F3, F4, F5
holding OMDA Series C Preferred Stock 05 Jun 2025 Common Stock 11.4K See footnotes F3, F4, F5
holding OMDA Series C-1 Preferred Stock 05 Jun 2025 Common Stock 8.28K See footnotes F3, F4, F5
holding OMDA Series D Preferred Stock 05 Jun 2025 Common Stock 10.7K See footnotes F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a 1-for-3 reverse stock split of the Issuer's outstanding common stock effected on May 27, 2025.
F2 Shares held by U.S. Venture Partners X, L.P.
F3 Shares held by USVP X Affiliates, L.P.
F4 Presidio Management Group X, L.L.C. ("PMG X"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
F5 Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock is convertible into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering after giving effect to the 1-for-3 reverse split of the Issuer's common stock effected on May 27, 2025. These shares are reported in Table II above on an as-converted basis and have no expiration date.

Remarks:

Exhibit 24.1 - Power of Attorney